» Articles » PMID: 29543810

Identification of Plasma Biomarkers for Discrimination Between Tuberculosis Infection/disease and Pulmonary Non Tuberculosis Disease

Overview
Journal PLoS One
Date 2018 Mar 16
PMID 29543810
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

We used the Luminex Bead Array Multiplex Immunoassay to measure cytokines, chemokines and growth factors responses to the same antigens used for RD1-based Interferon γ Release Assay (IGRA) test. Seventy-nine individuals, 27 active TB, 32 latent infection subsets, 20 individuals derivative purified protein (PPD) negative (subjects that do not have any indurative cutaneous reaction after 72 hrs of intradermal injection of PPD) and with other pulmonary disease were retrospectively studied. Forty-eight analytes were evaluated by Luminex Assay in plasma obtained from whole blood stimulated cells. The diagnostic accuracies of the markers detected were evaluated by ROC curve analysis and by the combination of multiple biomarkers to improve the potential to discriminate between infection/disease and non infection. Among 48 cytokines, 13 analytes, namely IL-3, IL-12-p40, LIF, IFNα2, IL-2ra, IL-13, b-NGF, SCF, TNF-β, TRAIL, IL-2, IFN-γ, IP-10, and MIG, were significantly higher in the active TB and LTBI groups, compared to NON-TB patients, while MIF was significantly lower in active TB patients compared to NON-TB and LTBI groups. The diagnostic accuracies of the markers detected in the culture supernatants evaluated by ROC curve analysis revealed that 11 analytes (IL2, IP10, IFN-γ, IL13, MIG, SCF, b-NGF, IL12-p40, TRAIL, IL2 Ra, LIF) discriminated between NON-TB and LTBI groups, with AUC for all analytes ≥0.73, while 14 analytes (IL2, IP10, IFN-γ, MIG, SCF, b-NGF, IL12-p40, TRAIL, IL2Ra, MIF, TNF-β, IL3, IFN-α2, LIF) discriminated between NON-TB and active TB groups, with AUC ≥0.78, that is a moderate, value in terms of accuracy of a diagnostic test. Finally, the combinations of seven biomarkers resulted in the accurate prediction of 88.89% of active TB patients, 82.35% of subjects with latent infection and 90% of non-TB patients, respectively. Taken together, our data suggest that combinations of whole blood Mycobacterium tuberculosis (Mtb) antigen dependent cytokines production could be useful as biomarkers to determine tuberculosis disease states when compared to non TB cohort.

Citing Articles

The Diagnostic Value of Interleukin-2 and Interferon-γ Induced by Fusion Protein (ESAT-6/CFP-10/Rv1985c) for Active Mycobacterium tuberculosis Infection.

Zhao Z, Li R, Zhao X, Wang Y, Lin M, Wei Q J Clin Lab Anal. 2025; 39(5):e70010.

PMID: 40019050 PMC: 11904813. DOI: 10.1002/jcla.70010.


Candidate serum protein biomarkers for active pulmonary tuberculosis diagnosis in tuberculosis endemic settings.

Ayalew S, Wegayehu T, Wondale B, Tarekegn A, Tessema B, Admasu F BMC Infect Dis. 2024; 24(1):1329.

PMID: 39573991 PMC: 11583743. DOI: 10.1186/s12879-024-10224-3.


Quantum Dot-Based Nanosensors for In Vitro Detection of .

Nikolaev V, Lepekhina T, Alliluev A, Bidram E, Sokolov P, Nabiev I Nanomaterials (Basel). 2024; 14(19).

PMID: 39404280 PMC: 11478040. DOI: 10.3390/nano14191553.


Antibodies as key mediators of protection against .

Wang Q, Nag D, Baldwin S, Coler R, McNamara R Front Immunol. 2024; 15:1430955.

PMID: 39286260 PMC: 11402706. DOI: 10.3389/fimmu.2024.1430955.


Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention.

Krivosova M, Dohal M, Masiarova S, Prso K, Gondas E, Murin R PLoS One. 2024; 19(8):e0305158.

PMID: 39208230 PMC: 11361567. DOI: 10.1371/journal.pone.0305158.


References
1.
Chegou N, Essone P, Loxton A, Stanley K, Black G, van der Spuy G . Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS One. 2012; 7(6):e38501. PMC: 3367928. DOI: 10.1371/journal.pone.0038501. View

2.
Chegou N, Black G, Kidd M, van Helden P, Walzl G . Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med. 2009; 9:21. PMC: 2696407. DOI: 10.1186/1471-2466-9-21. View

3.
Berry M, Graham C, McNab F, Xu Z, Bloch S, Oni T . An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010; 466(7309):973-7. PMC: 3492754. DOI: 10.1038/nature09247. View

4.
Kik S, Denkinger C, Casenghi M, Vadnais C, Pai M . Tuberculosis diagnostics: which target product profiles should be prioritised?. Eur Respir J. 2014; 44(2):537-40. DOI: 10.1183/09031936.00027714. View

5.
Kellar K, Gehrke J, Weis S, Mahmutovic-Mayhew A, Davila B, Zajdowicz M . Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One. 2011; 6(11):e26545. PMC: 3221668. DOI: 10.1371/journal.pone.0026545. View